New 'pulsed field' heart procedure aims to stop AFib without long-term drugs

NCT ID NCT06099730

Recruiting now Disease control Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times

Summary

This study tests a new procedure using pulsed field energy to treat atrial fibrillation (AFib), a common heart rhythm problem. The procedure isolates the pulmonary veins and the back wall of the left atrium to stop abnormal signals. About 442 adults with symptomatic AFib will be enrolled and followed for 12 months to see if the treatment is safe and effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation paroxysmal atrial fibrillation persistent atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION

Contacts and locations

Locations

Beth Israel Deaconess Medical Center
ACTIVE_NOT_RECRUITING

Boston, Massachusetts, 02215, United States
Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States
Montefiore Medical Center
RECRUITING

New York, New York, 10467, United States
Mount Sinai Hospital
NOT_YET_RECRUITING

New York, New York, 10029, United States
St. Bernard's Heart and Vascular Center
RECRUITING

Jonesboro, Arkansas, 72401, United States
Texas Cardiac Arrhythmia Institute/Research Foundation
RECRUITING

Austin, Texas, 78705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.